EUVIMEDEUVIMED entdecken
Crossref

ROS-activated MAPK/ERK pathway regulates crosstalk between Nrf2 and Hif-1α to promote IL-17D expression protecting the intestinal epithelial barrier under hyperoxia

Pingchuan Wang, Tianming Li, Changping Niu, Siyu Sun, Dongyan Liu

International Immunopharmacology · 2023-03 · 116 · 109763

DOI: 10.1016/j.intimp.2023.109763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-03. Verfasst von Pingchuan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: ShengJing Hospital of China Medical University, Department of Gastroenterology and Medical Research Center, Liaoning Key Laboratory of Research and A…. Hauptthemen laut MEDLINE: Hyperoxia, Interleukin-27. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen species (ROS) damage to the intestinal barrier is a side effect of prolonged hyperoxia therapy in neonates, which impairs growth and development of the intestine and promotes intestinal diseases. However, the research on clinical prevention and treatment is lacking. Therefore, we investigated the molecular mechanisms of the neonate intestinal response against hyperoxia-derived ROS to find targets for intestinal barrier damage prevention. Human intestinal epithelial cells were incubated under hyperoxia (85% oxygen) to build an in vitro model. ROS and the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway were inhibited to detect the MAPK/ERK pathway, nuclear factor erythroid factor 2-related factor 2 (Nrf2), hypoxia-inducible factor-1α (Hif-1α), and interleukin-17D (IL-17D) expression. Nrf2 was inhibited to detect Hif-1α and IL-17D expression. Hif-1α was inhibited to detect Nrf2, IL-17D, and tight junction proteins expression and apoptosis. Cells were treated with human recombinant IL-17D to detect TNF-α, IL-1β, IL-10, and tight junction proteins expression. ROS, Nrf2, Hif-1α, and IL-17D were upregulated and the MAPK/ERK pathway was activated under hyperoxia. But ROS inhibition downregulated the MAPK/ERK pathway, Nrf2, Hif-1α, and IL-17D. MAPK/ERK pathway inhibition downregulated Nrf2, Hif-1α, and IL-17D. Nrf2 inhibition downregulated Hif-1α and IL-17D. Hif-1α inhibition downregulated Nrf2, IL-17D, tight junction proteins, and exacerbated apoptosis. The recombinant IL-17D downregulated TNF-α, IL-1β, but upregulated IL-10 and tight junction proteins. We concluded that Hyperoxia-generated ROS activated the MAPK/ERK pathway to regulate Nrf2, Hif-1α, and IL-17D expression. Nrf2 and Hif-1α were interdependent and promoted IL-17D. Importantly, Hif-1α and IL-17D expression protected the intestinal epithelial barrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperoxiaInterleukin-27HumansInfant, NewbornExtracellular Signal-Regulated MAP KinasesHypoxia-Inducible Factor 1, alpha SubunitInterleukin-10IntestinesMAP Kinase Signaling SystemNF-E2-Related Factor 2Reactive Oxygen SpeciesTight Junction ProteinsTumor Necrosis Factor-alphaInterleukin-17

Stichwörter der Autor:innen

Hif-1αHyperoxia therapyIL-17DIntestinal barrierNrf2

Substanzen

Extracellular Signal-Regulated MAP KinasesHypoxia-Inducible Factor 1, alpha SubunitInterleukin-10Interleukin-27NF-E2-Related Factor 2Reactive Oxygen SpeciesTight Junction ProteinsTumor Necrosis Factor-alphaNFE2L2 protein, humanHIF1A protein, human

Autor:innen und Institutionen

  • ShengJing Hospital of China Medical University, Department of Gastroenterology and Medical Research Center, Liaoning Key Laboratory of Research and Application of Animal Models for Environmental and Metabolic Diseases,…
  • ShengJing Hospital of China Medical University, Department of Gastroenterology, SanHao Street No.36, HePing District, ShenYang, Liaoning 110000, China.

Zitieren

APA

Wang, P., Li, T., Niu, C., Sun, S., & Liu, D. (2023). ROS-activated MAPK/ERK pathway regulates crosstalk between Nrf2 and Hif-1α to promote IL-17D expression protecting the intestinal epithelial barrier under hyperoxia. International Immunopharmacology, 116, 109763. https://doi.org/10.1016/j.intimp.2023.109763

Vancouver

Wang P, Li T, Niu C, Sun S, Liu D. ROS-activated MAPK/ERK pathway regulates crosstalk between Nrf2 and Hif-1α to promote IL-17D expression protecting the intestinal epithelial barrier under hyperoxia. International Immunopharmacology. 2023;116:109763. doi:10.1016/j.intimp.2023.109763

BibTeX
@article{Wang2023,
  author = {Wang, Pingchuan and Li, Tianming and Niu, Changping and Sun, Siyu and Liu, Dongyan},
  title = {ROS-activated MAPK/ERK pathway regulates crosstalk between Nrf2 and Hif-1α to promote IL-17D expression protecting the intestinal epithelial barrier under hyperoxia},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {116},
  pages = {109763},
  doi = {10.1016/j.intimp.2023.109763}
}
Kostenlos starten →